Evidence map›Paper›PMID 30671016›Full record

ReviewFrontiers in neurology2018

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis.

Malcolm Proudfoot, Peter Bede, Martin R Turner

Abstract readReview
In one paragraph

Review in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. New developments in imaging in ALS.Journal of neurology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Premorbid brain structure influences risk of amyotrophic lateral sclerosis.Journal of neurology, neurosurgery, and psychiatry · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Malcolm ProudfootNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Peter BedeComputational Neuroimaging Group, Academic Unit of Neurology, Trinity College Dublin, Dublin, Ireland.
Martin R TurnerNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.

Funding

Medical Research Council MR/K01014X/1Motor Neurone Disease Association TURNER/OCT18/989-797
6 · The paper itself

Abstract

Advances in neuroimaging, complementing histopathological insights, have established a multi-system involvement of cerebral networks beyond the traditional neuromuscular pathological view of amyotrophic lateral sclerosis (ALS). The development of effective disease-modifying therapy remains a priority and this will be facilitated by improved biomarkers of motor system integrity against which to assess the efficacy of candidate drugs. Functional MRI (FMRI) is an established measure of both cerebral activity and connectivity, but there is an increasing recognition of neuronal oscillations in facilitating long-distance communication across the cortical surface. Such dynamic synchronization vastly expands the connectivity foundations defined by traditional neuronal architecture. This review considers the unique pathogenic insights afforded by the capture of cerebral disease activity in ALS using FMRI and encephalography.

Indexed as

amyotrophic lateral sclerosisbiomarkercortexmotor neurone diseaseneuroimagingneurophysiology

Identifiers

PMID30671016
PMCPMC6332509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.